Evaluation of polycyclic aromatic hydrocarbons in the activation of early growth response-1 and peroxisome proliferator activated receptors

Toxicological Sciences

Volumn 85, Issue 1, 2005, Pages 585-593

  Kim, Jeong Ho ^a   Yamaguchi, Kiyoshi ^a   Lee, Seong Ho ^a   Tithof, Patricia K ^a   Sayler, Gary S ^a   Yoon, Joo Heon ^b   Baek, Seung Joon ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

EGR 1; GSK 3 ; PAHs; PPAR ; PPAR

Indexed keywords

1 METHYLANTHRACENE; 1,1,2 TRIPHENYLETHYLENE DERIVATIVE; ACENAPHTHENE DERIVATIVE; ACENAPHTHYLENE; ANTHRACENE; BENZ[A]ANTHRACENE; BENZO[A]PYRENE; BENZO[B]FLUORANTHENE; BENZO[K]FLUORANTHENE; CHRYSENE; DIBENZOFURAN; EARLY GROWTH RESPONSE FACTOR 1; FLUORANTHENE; GLYCOGEN SYNTHASE KINASE 3BETA; LUCIFERASE; NAPHTHALENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHENANTHRENE; POLYCYCLIC AROMATIC HYDROCARBON; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PYRENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; ENZYME INHIBITION; FLOODPLAIN; GENE ACTIVATION; GENE TARGETING; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; REPORTER GENE; TRANSCRIPTION REGULATION; UNITED STATES; UPREGULATION; WATER CONTAMINATION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION; GENES, REPORTER; HUMANS; IMMEDIATE-EARLY PROTEINS; LUCIFERASES; MICE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; POLYCYCLIC HYDROCARBONS, AROMATIC; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS;

APOGON BRACHYGRAMMUS;

EID: 18144394716     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfi118     Document Type: Article

References (52)

1. Baek, S. J., Horowitz, J. M., and Eling, T. E. (2001). Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J. Biol. Chem. 276, 33384-33392.
2. Baek, S. J., Kim, J. S., Moore, S. M., Lee, S. H., Martinez, J., and Eling, T. E. (2005). Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol. 67, 356-364.
3. Baek, S. J., Kim, J. S., Nixon, J. B., DiAugustine, R. P., and Eling, T. E, (2004). Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J. Biol. Chem. 279, 6883-6892.
4. Baek, S. J., Wilson, L. C., Hsi, L. C., and Eling, T. E. (2003). Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. J. Biol. Chem. 278, 5845-5853.
5. Berger, J., and Moller, D. E. (2002). The mechanisms of action of PPARs. Annu. Rev. Med. 53, 409-435.
6. Breslow, J. L. (1996). Mouse models of atherosclerosis. Science 272, 685-698.
7. Cajaraville, M. P., Cancio, I., Ibabe, A., and Orbea, A. (2003). Peroxisome proliferation as a biomarker in environmental pollution assessment. Microsc. Res. Tech. 61, 191-202.
8. Calogero, A., Lombari, V., De Gregorio, G., Porcellini, A., Ucci, S., Arcella, A., Caruso, R., Gagliardi, F. M., Gulino, A., Lanzetta, G., Frati, L., Mercola, D., and Ragona, G. (2004). Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma. Cancer CelL Int. 4, 1.
9. Collett, G. P., Betts, A. M., Johnson, M. I., Pulimood, A. B., Cook, S., Neal, D. E., and Robson, C. N. (2000). Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma. Clin, Cancer Res. 6, 3241-3248.
10. Couture, L. A., Harris, M. W., and Birnbaum, L, S. (1990). Characterization of the peak period of sensitivity for the induction of hydronephrosis in C57BL/6N mice following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 15, 142-150.
11. Di-Poi, N., Tan, N. S., Michalik, L., Wahli, W., and Desvergne, B. (2002). Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell. 10, 721-733.
12. Eid, M. A., Kumar, M. V., Iczkowski, K. A., Bostwick, D. G., and Tindall, D. J. (1998). Expression of early growth response genes in human prostate cancer. Cancer Res. 58, 2461-2468.
13. Gashler, A., and Sukhatme, V. P. (1995). Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50, 191-224.
14. Gupta, R. A., Wang, D., Katkuri, S., Wang, H., Dey, S. K., and DuBois, R. N. (2004). Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat. Med. 10, 245-247.
15. Gustavsson, P., Alfredsson, L., Brunnberg, H., Hammar, N., Jakobsson, R., Reuterwall, C., and Ostlin, P. (1996). Myocardial infarction among male bus, taxi, and lorry drivers in middle Sweden. Occup. Environ. Med. 53, 235-240.
16. Gustavsson, P., Plato, N., Hallqvist, J., Hogstedt, C., Lewne, M., Reuterwall, C., and Scheele, P. (2001). A population-based case-referent study of myocardial infarction and occupational exposure to motor exhaust, other combustion products, organic solvents, lead, and dynamite. Stockholm Heart Epidemiology Program (SHEEP) Study Group. Epidemiology 12, 222-228.
17. Hansen, J. B., Zhang, H., Rasmussen, T. H., Petersen, R. K., Flindt, E. N., and Kristiansen, K. (2001). Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on CAMP signaling. J. Biol. Chem 276, 3175-3182.
18. Hao, M. W., Liang, Y. R., Liu, Y. F., Liu, L., Wu, M. Y., and Yang, H. X. (2002). Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J. Gastroenterol. 8, 203-207.
19. Hardt, S. E., and Sadoshima, J. (2002). Glycogen synthase kinase-3beta: A novel regulator of cardiac hypertrophy and development. Circ. Res. 90, 1055-1063.
20. Harja, E., Bucciarelli, L. G., Lu, Y., Stern, D. M., Zou, Y. S., Schmidt, A. M., and Yan, S. F. (2004). Early growth response-1 promotes atherogenesis: mice deficient in early growth response- 1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ. Res. 94, 333-339.
21. He, T. C., Chan, T. A., Vogelstein, B., and Kinzler, K. W. (1999). PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335-345.
22. Hecht, S. S., Amin, S., Lin, J. M., Rivenson, A., Kurtzke, C., and el-Bayoumy, K.(1995). Mammary carcinogenicity in female CD rats of a diol epoxide metabolite of fluoranthene, a commonly occurring environmental pollutant. Carcinogenesis 16, 1433-1435.
23. Huang, R. P., Fan, Y., and Boynton, A. L. (1999). UV irradiation upregulates Egr-1 expression at transcription level. J. Cell Biochem. 73, 227-236.
24. Huang, R. P., Fan, Y., de Belle, I., Niemeyer, C., Gottardis, M. M., Mercola, D., and Adamson, E. D. (1997). Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation, Int. J. Cancer 72, 102-109.
25. Incardona, J. P., Collier, T. K., and Scholz, N. L. (2004). Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 196, 191-205.
26. Israelian-Konaraki, Z., and Reaven, P. D. (2004). Peroxisome proliferator-activated receptor-alpha and atherosclerosis: From basic mechanisms to clinical implications. Cardiology 103, 1-9.
27. Johnson, E., Palmer, C., Griffin, K., and Hsu, M. (1996). Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 10, 1241-1248.
28. Khachigian, L. M., and Collins, T. (1998). Early growth response factor 1: A pleiotropic mediator of inducible gene expression. J. Mol. Med. 76, 613-616.
29. Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M, Roberts, R. A., and Fenner-Crisp, P. A. (2003). PPARalpha agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33, 655-780.
30. Lee, S. H., and Blair, I. A. (2001). Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc. Med. 11, 149-155.
31. Levin, W. J., Press, M. E, Gaynor, R. B., Sukhatine, V. P., Boone, T. C., Reissmann, P. T., Figlin, R. A., Holmes, E. C., Souza, L. M., and Slamon, D. J. (1995). Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene 11, 1261-1269.
32. Machala, M., Vondracek, J., Blaha, L., Ciganek, M., and Neca, J. V. (2001). Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay. Mutat. Res. 497, 49-62.
33. Martinez, J. M., Baek, S. J., Mays, D. M., Tithof, P. K., Eling, T. E., and Walker, N. J. (2004). EGR1 is a novel target for AhR agonists in human lung epithelial cells. Toxicol. Sci. 82, 429-435.
34. Marx, N., Duez, H., Fruchart, J. C., and Staels, B. (2004). Peroxisome proliferator-activated receptors and atherogenesis: Regulators f gene expression in vascular cells. Circ. Res. 94, 1168-1178.
35. McCaffrey, T. A., Fu, C., Du, B., Eksinar, S., Kent, K. C., Bush, H., Jr., Kreiger, K., Rosengart, T., Cybulsky, M. I., Silverman, E. S., and Collins, T. (2000). High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J. Clin, Invest. 105, 653-662.
36. Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y, and Dalton, T. P. (2000). Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59, 65-85.
37. Nixon, J. B., Kamitani, H., Baek, S. J., and Eling, T. E. (2003). Evaluation of eicosanoids and NSAIDs as PPARgamma ligands in colorectal carcinoma cells. Prostaglandins Leukot. Essent. Fatty Acids 68, 323-330.
38. Park, B. H., Vogelstein, B., and Kinzler, K. W. (2001). Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc. Natl. Acad. Sci, U.S.A. 98, 2598-2603.
39. Rubin, H. (2001). Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: A bio-historical perspective with updates. Carcinogenesis 22, 1903-1930.
40. Shozu, M., Murakami, K., Segawa, T, Kasai T., Ishikawa, H., Shinohara, K., Okada, M., and Inoue, M. (2004). Decreased expression of early growth response-1 and its role in uterine leiomyoma growth. Cancer Res. 64, 4677-4684.
41. Silverman, E. S., and Collins, T. (1999). Pathways of Egr-1-mediate gene transcription in vascular biology. Am. J. Pathol. 154, 665-670.
42. Suchanek, K. M., May, F. J., Robinson, J. A., Lee, W. J., Holman, N. A., Monteith, G. R., and Roberts-Thomson, S. J. (2002). Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol. Carcinog. 34, 165-171.
43. Thigpen, A. E., Cala, K. M., Guileyardo, J. M., Molberg, K. H., McConnell, J. D., and Russell, D. W. (1996). Increased expression of early growth response-1 messenger ribonucleic acid in prostatic adenocarcinoma. J. Urol. 155, 975-981.
44. Thirman, M. J., Albrecht, J. H., Krueger, M. A., Erickson, R. R., Cherwitz, D. L., Park, S. S., Gelboin, H. V., and Holtzman, J. L. (1994). Induction of cytochrome CYPIAI and formation of toxic metabolites of benzo[a]pyrene by rat aorta: A possible role in atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 91, 5397-5401.
45. Tong, B. J., Tan, J., Tajeda, L., Das, S. K., Chapman, J. A., DuBois, R. N., and Dey, S. K. (2000). Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia 2, 483-490.
46. Toraason, M., Hayden, C., Marlow, D., Rinehart, R., Mathias, P., Werren, D., Olsen, L. D., Neumeister, C. E., Mathews, E. S., Cheever, K. L., Marlow, K. L., DeBord, D. G., and Reid, T. M. (2001). DNA strand breaks, oxidative damage, and 1-OH pyrene in roofers with coal-tar pitch dust and/or asphalt fume exposure. Int. Arch. Occup. Environ. Health 74, 396-404.
47. Vanden Heuvel, J. P., Kreder, D., Belda, B., Hannon, D. B., Nugent, C. A., Burns, K. A., and Taylor, M. J. (2003). Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643. Toxicol. Appl. Pharmacol. 188, 185-98.
48. Wang, D., Wang, H., Shi, Q., Katkuri, S., Walhi, W., Desvergne, B., Das, S. K., Dey, S. K., and DuBois, R. N. (2004). Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell 6, 285-295.
49. WHO (1998). Environmental Health Criteria 202: Selected non-heterocyclic polycyclic aromatic hydrocarbons. In IPCS, International Programme on Chemical Safety. World Health Organisation, Geneva.
50. Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H., and Loeb, L. A. (2004). Environmental and chemical carcinogenesis. Semin. Cancer Biol. 14, 473-486.
51. Yamaguchi, K., Lee, S. H., Eling, T. E., and Baek, S. J. (2004). Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway. J. Biol. Chem. 279, 49617-49623.
52. Zhang, W., Yan, S. D., Zhu, A., Zou, Y. S., Williams, M., Godman, G. C., Thomashow, B. M., Ginsburg, M. E., Stem, D. M., and Yan, S. F. (2000). Expression of Egr-1 in late stage emphysema. Am. J. Pathol. 157, 1311-1320.